Cash Holders STILL Aren't Taking Steps to Prepare

Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.

IGMS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 55.96%

Insider Buying (Last 12 Months): $1,676,435.95

Insider Selling (Last 12 Months): $2,004,870.11

IGM Biosciences Insider Trading History Chart

IGM Biosciences Share Price & Price History

^$24.00

▼ -1.4 (-5.51%)

As of 02/3/2023 10:04 PM ET

Days: 30 | 90 | 365

Cash Holders STILL Aren't Taking Steps to Prepare

From Investor Place Media | Ad

Click Here to Learn More

IGM Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/19/2022	Misbah Tahir	CFO	Sell	3,801	$20.00	$76,020.00	27,090
12/16/2022	Chris H Takimoto	Insider	Sell	5,430	$18.98	$103,061.40	30,557
12/16/2022	Fred Schwarzer	CEO	Sell	12,369	$18.98	$234,763.62	20,360
12/16/2022	Misbah Tahir	CFO	Sell	2,283	$18.98	$43,331.34	30,891
11/23/2022	Chris H Takimoto	Insider	Sell	877	$21.57	$18,916.89	35,987
11/23/2022	Fred Schwarzer	CEO	Sell	1,258	$21.57	$27,135.06	32,729
11/8/2022	M Kathleen Behrens	Director	Buy	60,000	$17.14	$1,028,400.00	218,200
10/4/2022	Bruce Keyt	Insider	Sell	25,000	$22.84	$571,000.00	39,489
9/29/2022	Michael D Loberg	Director	Buy	5,821	$19.62	$114,208.02	35,305
9/27/2022	Michael D Loberg	Director	Buy	507	$19.99	$10,134.93	23,312
9/8/2022	Bruce Keyt	Insider	Sell	10,000	$19.78	$197,800.00	39,489
9/6/2022	Bruce Keyt	Insider	Sell	5,000	$19.06	$95,300.00	39,489
8/22/2022	Bruce Keyt	Insider	Sell	6,300	$20.71	$130,473.00	39,489
8/19/2022	Bruce Keyt	Insider	Sell	8,700	$22.82	$198,534.00	39,489
5/26/2022	Misbah Tahir	CFO	Sell	950	$17.10	$16,245.00	33,698
5/24/2022	Chris H Takimoto	Insider	Sell	938	$17.10	$16,039.80	36,864
5/20/2022	Jakob Haldor Topsoe	Director	Buy	1,481	$16.00	$23,696.00	73,462
4/6/2022	Bruce Keyt	Insider	Sell	2,500	$25.00	$62,500.00	40,015
4/1/2022	Michael D Loberg	Director	Buy	21,739	$23.00	$499,997.00	2,646
3/30/2022	Bruce Keyt	Insider	Sell	7,500	$28.50	$213,750.00
11/2/2021	Bruce Keyt	Insider	Sell	1,326	$51.37	$68,116.62
10/5/2021	Bruce Keyt	Insider	Sell	1,242	$64.10	$79,612.20
9/3/2021	Bruce Keyt	Insider	Sell	1,244	$70.69	$87,938.36	5,557
8/9/2021	Julie Hambleton	Director	Sell	1,000	$80.00	$80,000.00
8/4/2021	Bruce Keyt	Insider	Sell	1,242	$67.00	$83,214.00
7/6/2021	Bruce Keyt	Insider	Sell	1,247	$82.50	$102,877.50
6/2/2021	Bruce Keyt	Insider	Sell	1,245	$79.15	$98,541.75	5,557
6/1/2021	Julie Hambleton	Director	Sell	2,000	$80.00	$160,000.00	3,000
5/26/2021	Daniel Shinyu Chen	Insider	Sell	444	$70.00	$31,080.00	116,518
5/5/2021	Bruce Keyt	Insider	Sell	1,243	$62.50	$77,687.50	5,269
4/6/2021	Bruce Keyt	Insider	Sell	1,254	$82.00	$102,828.00	5,269
3/2/2021	Bruce Keyt	Insider	Sell	1,619	$90.25	$146,114.75	5,269
2/3/2021	Bruce Keyt	Insider	Sell	1,619	$96.00	$155,424.00	5,269
1/4/2021	Bruce Keyt	Insider	Sell	883	$88.07	$77,765.81	5,269
12/17/2020	Bruce Keyt	Insider	Sell	1,618	$86.10	$139,309.80	5,269
12/11/2020	Jakob Haldor Topsoe	Director	Buy	111,111	$90.00	$9,999,990.00	54,949
12/8/2020	Daniel Shinyu Chen	Insider	Sell	1,219	$91.00	$110,929.00	118,373
12/2/2020	Daniel Shinyu Chen	Insider	Sell	608	$63.15	$38,395.20	117,423
11/4/2020	Daniel Shinyu Chen	Insider	Sell	605	$50.00	$30,250.00	117,468
10/2/2020	Daniel Shinyu Chen	Insider	Sell	1,830	$73.50	$134,505.00	119,368
9/18/2020	Daniel Shinyu Chen	Insider	Sell	609	$77.91	$47,447.19	117,468
9/10/2020	Bruce Keyt	Insider	Sell	1,000	$60.00	$60,000.00	2,637
9/10/2020	M Kathleen Behrens	Director	Buy	30,000	$60.78	$1,823,400.00	64,192
9/8/2020	Daniel Shinyu Chen	Insider	Sell	602	$50.20	$30,220.40	116,518
9/8/2020	Redmile Group, Llc	Director	Buy	47,113	$49.91	$2,351,409.83
9/3/2020	Redmile Group, Llc	Director	Buy	74,253	$48.69	$3,615,378.57
9/1/2020	Redmile Group, Llc	Director	Buy	41,759	$44.84	$1,872,473.56
8/27/2020	Daniel Shinyu Chen	Insider	Sell	605	$45.13	$27,303.65	116,518

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

SEC Filings (Institutional Ownership Changes) for IGM Biosciences (NASDAQ:IGMS)

41.41% of IGM Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

IGM Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/8/2022	Bank of New York Mellon Corp	66,345	$1.51M	0.0%	+94.5%	0.155%
11/21/2022	California State Teachers Retirement System	12,429	$0.28M	0.0%	+5.1%	0.029%
11/16/2022	BNP Paribas Arbitrage SNC	11,645	$0.27M	0.0%	N/A	0.027%
11/15/2022	Alliancebernstein L.P.	24,296	$0.55M	0.0%	-2.4%	0.057%
11/15/2022	State Street Corp	221,950	$5.05M	0.0%	+18.5%	0.518%
11/15/2022	Two Sigma Investments LP	9,281	$0.21M	0.0%	N/A	0.022%
11/15/2022	UBS Asset Management Americas Inc.	524,311	$11.92M	0.0%	-2.3%	1.224%
11/15/2022	Vanguard Group Inc.	519,977	$11.82M	0.0%	+1.8%	1.214%
11/15/2022	Price T Rowe Associates Inc. MD	2,217,766	$50.43M	0.0%	-15.4%	5.178%
11/15/2022	Marshall Wace LLP	246,689	$5.61M	0.0%	-2.4%	0.576%
11/15/2022	Ensign Peak Advisors Inc	1,890	$43K	0.0%	+27.7%	0.004%
11/15/2022	Bank of New York Mellon Corp	66,345	$1.51M	0.0%	+94.5%	0.155%
11/15/2022	BlackRock Inc.	739,932	$16.83M	0.0%	+2.2%	1.728%
11/14/2022	Royal Bank of Canada	4,329	$99K	0.0%	+110.5%	0.010%
11/14/2022	Delphia USA Inc.	10,185	$0.23M	0.3%	N/A	0.024%
11/14/2022	Cubist Systematic Strategies LLC	19,801	$0.45M	0.0%	-11.6%	0.046%
11/14/2022	PDT Partners LLC	13,126	$0.30M	0.0%	-9.3%	0.031%
11/14/2022	Renaissance Technologies LLC	12,600	$0.29M	0.0%	-64.4%	0.029%
11/14/2022	Nuveen Asset Management LLC	45,184	$1.03M	0.0%	-48.5%	0.106%
11/10/2022	ExodusPoint Capital Management LP	25,485	$0.58M	0.0%	N/A	0.060%
11/10/2022	Dimensional Fund Advisors LP	45,669	$1.04M	0.0%	-36.7%	0.107%
11/10/2022	Tower Research Capital LLC TRC	2,019	$46K	0.0%	-58.4%	0.005%
11/7/2022	Quantbot Technologies LP	3,600	$81K	0.0%	N/A	0.008%
11/7/2022	Jump Financial LLC	26,900	$0.61M	0.0%	+3.2%	0.063%
11/3/2022	Barclays PLC	1,951	$44K	0.0%	-78.8%	0.005%
11/2/2022	Victory Capital Management Inc.	80,450	$1.83M	0.0%	-1.0%	0.189%
10/31/2022	SG Americas Securities LLC	6,322	$0.14M	0.0%	N/A	0.015%
10/26/2022	Allspring Global Investments Holdings LLC	2,729	$62K	0.0%	N/A	0.006%
10/25/2022	Raymond James & Associates	40,633	$0.92M	0.0%	+4.9%	0.096%
8/23/2022	Captrust Financial Advisors	2,750	$50K	0.0%	N/A	0.006%
8/19/2022	Eagle Bay Advisors LLC	41,635	$0.75M	0.5%	+19.5%	0.098%
8/18/2022	Goldman Sachs Group Inc.	198,554	$3.58M	0.0%	-53.6%	0.467%
8/16/2022	Captrust Financial Advisors	2,750	$50K	0.0%	N/A	0.006%
8/16/2022	Jane Street Group LLC	20,110	$0.36M	0.0%	N/A	0.047%
8/16/2022	Woodline Partners LP	200,047	$3.61M	0.1%	-50.4%	0.470%
8/16/2022	Price T Rowe Associates Inc. MD	2,622,873	$47.29M	0.0%	+16.8%	6.167%
8/15/2022	State Street Corp	187,261	$3.38M	0.0%	+9.1%	0.440%
8/15/2022	PDT Partners LLC	14,478	$0.26M	0.0%	-23.4%	0.034%
8/15/2022	Cubist Systematic Strategies LLC	22,400	$0.40M	0.0%	+169.7%	0.053%
8/15/2022	Millennium Management LLC	589,401	$10.63M	0.0%	+166.3%	1.386%
8/15/2022	UBS Asset Management Americas Inc.	536,409	$9.67M	0.0%	-4.3%	1.261%
8/15/2022	Alpha Paradigm Partners LLC	8,939	$0.16M	0.1%	N/A	0.021%
8/13/2022	Renaissance Technologies LLC	35,400	$0.64M	0.0%	-44.9%	0.083%
8/13/2022	American International Group Inc.	4,684	$84K	0.0%	+15.0%	0.011%
8/12/2022	Northern Trust Corp	110,606	$1.99M	0.0%	+30.6%	0.260%
8/12/2022	Virtus ETF Advisers LLC	7,267	$0.13M	0.0%	+32.9%	0.017%
8/12/2022	Ensign Peak Advisors Inc	1,480	$27K	0.0%	-96.8%	0.003%
8/12/2022	Credit Suisse AG	5,390	$98K	0.0%	N/A	0.013%
8/12/2022	Rhumbline Advisers	12,883	$0.23M	0.0%	+39.7%	0.030%
8/11/2022	JPMorgan Chase & Co.	9,961	$0.18M	0.0%	-14.4%	0.023%
8/9/2022	Swiss National Bank	21,500	$0.39M	0.0%	+16.2%	0.051%
8/5/2022	State Board of Administration of Florida Retirement System	14,748	$0.27M	0.0%	N/A	0.035%
8/1/2022	US Bancorp DE	1,534	$28K	0.0%	-37.1%	0.004%
8/1/2022	Victory Capital Management Inc.	81,263	$1.47M	0.0%	+684.1%	0.191%
7/25/2022	Strs Ohio	5,200	$93K	0.0%	N/A	0.012%
6/30/2022	Amalgamated Bank	1,335	$36K	0.0%	N/A	0.003%
6/7/2022	Bank of America Corp DE	4,113	$0.11M	0.0%	-74.3%	0.010%
5/17/2022	Royal Bank of Canada	2,503	$66K	0.0%	-31.4%	0.006%
5/16/2022	California State Teachers Retirement System	10,048	$0.27M	0.0%	-7.4%	0.024%
5/16/2022	Goldman Sachs Group Inc.	428,087	$11.44M	0.0%	+6.1%	1.039%
5/16/2022	PDT Partners LLC	18,909	$0.51M	0.0%	N/A	0.046%
5/16/2022	State Street Corp	171,582	$4.59M	0.0%	-76.6%	0.417%
5/16/2022	UBS Group AG	1,093	$29K	0.0%	-97.9%	0.003%
5/13/2022	Renaissance Technologies LLC	64,200	$1.72M	0.0%	+413.6%	0.156%
5/13/2022	Northern Trust Corp	84,672	$2.26M	0.0%	+9.2%	0.206%
5/13/2022	Charles Schwab Investment Management Inc.	102,623	$2.74M	0.0%	+79.7%	0.249%
5/13/2022	Vanguard Group Inc.	830,077	$22.19M	0.0%	+100.0%	2.015%
5/13/2022	Dimensional Fund Advisors LP	56,199	$1.50M	0.0%	-3.5%	0.136%
5/12/2022	BlackRock Inc.	694,824	$18.57M	0.0%	+2.6%	1.687%
5/12/2022	Rhumbline Advisers	9,222	$0.25M	0.0%	+16.5%	0.022%
5/12/2022	Artal Group S.A.	2,000,000	$53.46M	2.2%	+33.3%	4.855%
5/12/2022	Citigroup Inc.	2,694	$72K	0.0%	-93.9%	0.007%
5/11/2022	US Bancorp DE	2,437	$65K	0.0%	+608.4%	0.006%
5/11/2022	Raymond James & Associates	40,067	$1.07M	0.0%	+90.8%	0.097%
5/11/2022	JPMorgan Chase & Co.	11,632	$0.31M	0.0%	+54.7%	0.028%
5/11/2022	GSA Capital Partners LLP	36,517	$0.98M	0.1%	+376.1%	0.089%
5/10/2022	TD Asset Management Inc.	32,559	$0.87M	0.0%	-34.9%	0.079%
5/9/2022	Swiss National Bank	18,500	$0.50M	0.0%	+8.8%	0.045%
5/6/2022	IndexIQ Advisors LLC	13,971	$0.37M	0.0%	N/A	0.034%
5/4/2022	Victory Capital Management Inc.	10,364	$0.17M	0.0%	-67.2%	0.025%
4/28/2022	DekaBank Deutsche Girozentrale	9,100	$0.24M	0.0%	+9.6%	0.022%
3/3/2022	Walleye Capital LLC	35,127	$1.03M	0.0%	N/A	0.108%
2/19/2022	Woodline Partners LP	403,401	$11.83M	0.2%	-29.1%	1.243%
2/14/2022	Virtus ETF Advisers LLC	5,787	$0.17M	0.1%	+161.5%	0.018%
2/14/2022	Redmile Group LLC	3,334,355	$97.80M	2.2%	-2.7%	10.272%
2/14/2022	Point72 Hong Kong Ltd	1,149	$34K	0.0%	N/A	0.004%
2/14/2022	GSA Capital Partners LLP	7,670	$0.23M	0.0%	+41.9%	0.024%
2/11/2022	Ensign Peak Advisors Inc	46,868	$1.37M	0.0%	-76.0%	0.144%
2/10/2022	Qube Research & Technologies Ltd	32,202	$0.94M	0.0%	N/A	0.099%
2/10/2022	Pictet Asset Management SA	934,965	$27.42M	0.0%	+60.0%	2.880%
2/10/2022	Rafferty Asset Management LLC	56,057	$1.64M	0.0%	+93.6%	0.173%
2/10/2022	Citigroup Inc.	44,362	$1.30M	0.0%	+118.3%	0.137%
2/10/2022	TD Asset Management Inc.	50,031	$1.47M	0.0%	+21.2%	0.154%
2/9/2022	Dimensional Fund Advisors LP	58,221	$1.71M	0.0%	+689.7%	0.179%
2/8/2022	Northern Trust Corp	77,544	$2.28M	0.0%	-3.7%	0.239%
2/7/2022	Victory Capital Management Inc.	31,611	$0.93M	0.0%	-7.4%	0.097%
2/1/2022	Qube Research & Technologies Ltd	32,202	$0.94M	0.0%	N/A	0.099%
1/21/2022	Russell Investments Group Ltd.	25,345	$0.74M	0.0%	-27.2%	0.078%
12/14/2021	UBS Asset Management Americas Inc.	315,967	$20.78M	0.0%	-5.8%	0.973%
11/16/2021	Two Sigma Investments LP	9,444	$0.62M	0.0%	+88.9%	0.029%

Data available starting January 2016

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

Today's Range

Now: $24.00

$23.82

$25.52

50 Day Range

MA: $20.43

$15.45

$25.76

52 Week Range

Now: $24.00

$12.67

$35.98

Volume

106,400 shs

Average Volume

197,296 shs

Market Capitalization

$1.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of IGM Biosciences?: IGM Biosciences' top insider shareholders include:
M Kathleen Behrens (Director)
Daniel Shinyu Chen (Insider)
Jakob Haldor Topsoe (Director)
Bruce Keyt (Insider)
Chris H Takimoto (Insider)
Michael D Loberg (Director)
Misbah Tahir (CFO)
Fred Schwarzer (CEO)
Julie Hambleton (Director)
Learn More about top insider investors at IGM Biosciences.
Who are the major institutional investors of IGM Biosciences?: IGM Biosciences' top institutional shareholders include:
Simplex Trading LLC — 0.00%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of IGM Biosciences stock.
Which institutional investors are selling IGM Biosciences stock?: During the last quarter, IGMS stock was sold by these institutional investors:
Simplex Trading LLC
Within the previous year, company insiders that have sold IGM Biosciences company stock include:
M Kathleen Behrens (Director)
Daniel Shinyu Chen (Insider)
Jakob Haldor Topsoe (Director)
Bruce Keyt (Insider)
Learn More investors selling IGM Biosciences stock.

Cash Holders STILL Aren't Taking Steps to Prepare

From Investor Place Media | Ad

Click Here to Learn More

IGMS Insider Trading

IGM Biosciences Insider Trading History Chart

IGM Biosciences Share Price & Price History

IGM Biosciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for IGM Biosciences (NASDAQ:IGMS)

Institutional Buying and Selling by Quarter

IGM Biosciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of IGM Biosciences?

Who are the major institutional investors of IGM Biosciences?

Which institutional investors are selling IGM Biosciences stock?